RT @BCD_AACR: #COVID19 Infections and Clinical Outcomes in Patients with #MultipleMyeloma in New York City: A Cohort Study from Five Academ…
#COVID19 Infections and Clinical Outcomes in Patients with #MultipleMyeloma in New York City: A Cohort Study from Five Academic Centers, by @MalinHultcrantz et al. https://t.co/49MYy6mlSK @MSKCancerCenter @TischCancer @MyelomaCenter @nyulangone @columbiaca
#COVID19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers by Landgren et al. https://t.co/tRrZc0Geif #AACRCOVIDReport
@LauraMeierD5 2/ Here are links to the statistics cited above https://t.co/zPyDMNhHa7 https://t.co/eRHZ7KYyO2 https://t.co/RQicqvtgUH\\ @LLSusa @theMMRF @IMFmyeloma @LevineCancer #We’reAllTired #KeepPoundingBloodCancerPatients
RT @DrGarethMorgan1: Great team work guys special thanks to Malin. #mmsm @nyulangone https://t.co/djSM2Fv9uJ
Great team work guys special thanks to Malin. #mmsm @nyulangone
2/ “There was a higher risk of adverse outcome (intensive care unit admission, mechanical ventilation, or death) in Hispanics/Latinos and African American Blacks as compared with White patients.” https://t.co/RQicqvtgUH
1/ “In this large case series on COVID-19 in patients with multiple myeloma, we report 29% mortality rates among hospitalized patients and identify race/ethnicity as the most significant risk factor for severe outcome.” https://t.co/RQicqvtgUH
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @retail_recruit: Don’t let the Conservatives kill more Canadians with disinformation. Accountability is coming for every preventable dea…
Don’t let the Conservatives kill more Canadians with disinformation. Accountability is coming for every preventable death Mr. Furey. #onpoli #cdnpoli #CrimesAgainstHumanity #ConPremiersKill #Cdnmediafailed
@anthonyfurey Myeloma cardiac condition is mild, treated with low dose ASPIRIN over 3-4 days and disappears. #Conservatives: killing Canadians with disinformation. As Brazil, we need a Royal Commission into criminal negligence of Con Premiers. #onpoli #cd
@DanaFarber Read the related article: COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers. https://t.co/S87Jc63OPB
@hana___anah Colin Powell was vaccinated, probably by early 2021. He was immunocompromised due to his age 84, cancer and Parkinson's. His cancer was multiple myeloma, a type of blood cancer that affects white blood cells. (Article • November 2020) https
RT @BCD_AACR: Don't miss Deepu Madduri's talk at #AACRMDT21 on #myeloma #immunotherapy. Read her recent article: https://t.co/qno6TNAoX0…
Don't miss Deepu Madduri's talk at #AACRMDT21 on #myeloma #immunotherapy. Read her recent article: https://t.co/qno6TNAoX0 #mmsm #CARTcell https://t.co/Ciyc9J7k7Q
RT @BCD_AACR: Tuning in to the #AACRCovid #COVID19nCancer meeting? Read this paper on #COVID19 and multiple #myeloma. @sloan_kettering @I…
Tuning in to the #AACRCovid #COVID19nCancer meeting? Read this paper on #COVID19 and multiple #myeloma. @sloan_kettering @IcahnMountSinai @WeillCornell @nyulangone @Columbia #mmsm https://t.co/ZrRZHtHP9M https://t.co/lUKwnwsX3A
RT @_TanyaBondar_: And the question of COVID in cancer came up again in Q&A. As @DMadduri and teams across NYC recently reported in two stu…
And the question of COVID in cancer came up again in Q&A. As @DMadduri and teams across NYC recently reported in two studies, there was no increased SARS-CoV-2 susceptibility in #myeloma patients: https://t.co/BA22XHfWeX https://t.co/surjDANop0
ICYMI: COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City— A Cohort Study from Five Academic Center. @sloan_kettering #ASH20 https://t.co/4e0FWdm8GZ https://t.co/5yo8hjEe9o
1,742/ New York City, USA (adult smoking rate was 13.4% in 2017) Of 126 with multiple myeloma or related plasma cell disorders & confirmed Covid-19, 34 were former or current smokers (27%) https://t.co/KDBvGboHEd
#COVID19 infections & outcomes in multiple myeloma in NYC: 5 academic center cohort study [Jul 30, 2020] @malinhultcrantz et al. @DrOlaLandgren @BCD_AACR https://t.co/eVMSuhDq8o #mmsm #COVID19nCancer n=100 @sloan_kettering @IcahnMountSinai @WeillCornel
COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers [Jun 11, 2020] @malinhultcrantz et al. @DrOlaLandgren @BCD_AACR PDF: https://t.co/7lrXPjId2f #mmsm #COVID19nCancer #COVI
RT @BCD_AACR: 2) COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Aca…
2) COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers. @sloan_kettering @TischCancer @MyelomaCenter @nyulangone @columbiacancer https://t.co/ch3DrtYr6j
2) COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Center. @sloan_kettering https://t.co/iPmL1E8JWZ
2) COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Center. @sloan_kettering https://t.co/iPmL1E8JWZ
#COVID19 infections & outcomes in multiple myeloma in NYC: 5 academic center cohort study [Jul 30, 2020] @malinhultcrantz et al. @DrOlaLandgren @BCD_AACR https://t.co/eVMSuhDq8o #mmsm #COVID19nCancer n=100 @sloan_kettering @IcahnMountSinai @WeillCornel
COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers [Jun 11, 2020] @malinhultcrantz et al. @DrOlaLandgren @BCD_AACR PDF: https://t.co/7lrXPjId2f #mmsm #COVID19nCancer #COV
Related article: COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers. https://t.co/OQigjALkzm
COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers [Jun 11, 2020] @malinhultcrantz et al. @DrOlaLandgren BCJ PDF: https://t.co/gTrDVmUeIy #mmsm #COVID19nCancer #COVID19
RT @mtmdphd: COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: a cohort study from five academi…
RT @mtmdphd: #COVID19 infections & outcomes in multiple myeloma in New York City: 5 academic center cohort study [Jul 30, 2020] @malinhultc…
#COVID19 infections & outcomes in multiple myeloma in New York City: 5 academic center cohort study [Jul 30, 2020] @malinhultcrantz et al. @DrOlaLandgren https://t.co/eVMSuhDq8o #mmsm #COVID19nCancer n=100 @sloan_kettering @IcahnMountSinai @WeillCornel
COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers [Jun 11, 2020] @malinhultcrantz et al. @DrOlaLandgren BCJ PDF: https://t.co/7lrXPjId2f #mmsm #COVID19nCancer #COVID19 #C
RT @mtmdphd: #COVID19 infections & outcomes in multiple myeloma in New York City: 5 academic center cohort study [Jul 30, 2020] @malinhultc…
#COVID19 infections & outcomes in multiple myeloma in New York City: 5 academic center cohort study [Jul 30, 2020] @malinhultcrantz et al. @DrOlaLandgren https://t.co/eVMSuhDq8o #mmsm #COVID19nCancer n=100 @sloan_kettering @IcahnMountSinai @WeillCornel
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers https://t.co/RgG26Yo288
RT @BCD_AACR: It reports 29% mortality rate in hospitalized patients and higher risk for severe outcomes in Black and Hispanic/Latino patie…
RT @_TanyaBondar_: Heading off to a session on health disparities among the lymphoma patients: #AACRLYMP20
RT @BCD_AACR: BCD Editor Editor Christopher Flowers is chairing Session 8 at #AACRLYMP20—Cancer Health Disparities in Lymphoma: How Do We I…
Attending #AMPC20? Read Francesco Maura and Ola Landgren's recent Blood Cancer Discovery article— COVID-19 infections and outcomes in patients with multiple myeloma in New York City: A cohort study from five academic centers. https://t.co/dKWplkEwzZ htt
#AMPC20 is free! Now @DrOlaLandgren and @FrancescoMaura4 are presenting important insights on molecular timing of multiple myeloma initiation. Check their recept work published in @BCD_AACR https://t.co/5N5dNMApES https://t.co/YHmLrzewRL
RT @_TanyaBondar_: Heading off to a session on health disparities among the lymphoma patients: #AACRLYMP20 https://t.co/XAwRXqIqFN
Heading off to a session on health disparities among the lymphoma patients: #AACRLYMP20
BCD Editor Editor Christopher Flowers is chairing Session 8 at #AACRLYMP20—Cancer Health Disparities in Lymphoma: How Do We Improve Outcomes? Read this related article showing race/ethnicity associated with #COVID19 mortality in multiple #myeloma: https
RT @docbraunstein: COVID-19 experience in #myeloma in NYC. https://t.co/rakgTcHcRd
COVID-19 experience in #myeloma in NYC. https://t.co/rakgTcHcRd
@MM_Hub @AbelPharma @torinotoday Looking forward to learning more about #COVID19 impact and clinical care of #myeloma in Europe. A report on COVID-19 outcomes in 100 patients with MM in New York just came out in Blood Cancer Discovery: https://t.co/a7BBjS
It reports 29% mortality rate in hospitalized patients and higher risk for severe outcomes in Black and Hispanic/Latino patients. Race/ethnicity is the strongest risk factor. #MMSM #COVID19nCancer #healthdisparities #Myeloma Read more here: https://t.co/5
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @BCD_AACR: It reports 29% mortality rate in hospitalized patients and higher risk for severe outcomes in Black and Hispanic/Latino patie…
RT @_TanyaBondar_: @UrviShahMD @malinhultcrantz @DrOlaLandgren @sloan_kettering Thank you for this timely work! Thrilled to have published…
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @BCD_AACR: It reports 29% mortality rate in hospitalized patients and higher risk for severe outcomes in Black and Hispanic/Latino patie…
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
RT @AuclairDan: Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @…
Colossal effort by a superteam, #COVID19 outcomes in largest #mmsm cohort to date from 5 NY hospitals @JoshuaRichterMD @DMadduri @UrviShahMD @malinhultcrantz @DrOlaLandgren @SLentzsch @DrGarethMorgan1 https://t.co/fjkyBA2Wgo
RT @mtmdphd: #COVID19 infections & outcomes in multiple myeloma in New York City: 5 academic center cohort study [Jul 30, 2020] @malinhultc…
#COVID19 infections & outcomes in multiple myeloma in New York City: 5 academic center cohort study [Jul 30, 2020] @malinhultcrantz et al. @DrOlaLandgren https://t.co/eVMSuhV0ZW #mmsm #COVID19nCancer n=100 @sloan_kettering @IcahnMountSinai @WeillCornel
RT @_TanyaBondar_: @JoshuaRichterMD Thank you for this timely work! Thrilled to have published it in Blood Cancer Discovery @BCD_AACR. The…
@JoshuaRichterMD Thank you for this timely work! Thrilled to have published it in Blood Cancer Discovery @BCD_AACR. The peer-reviewed, revised version of the article is free to read here: https://t.co/a7BBjTd9OH.
@UrviShahMD @malinhultcrantz @DrOlaLandgren @sloan_kettering Thank you for this timely work! Thrilled to have published it in Blood Cancer Discovery: https://t.co/a7BBjTd9OH. The peer-reviewed, revised version of the article is free to read @BCD_AACR.
@AlGarfall One is now published in Blood Cancer Discovery: https://t.co/a7BBjSVyX9. The peer-reviewed, revised version of the article is free to read @BCD_AACR.
RT @_TanyaBondar_: It reports 29% mortality rate in hospitalized patients and higher risk for severe outcomes in Black and Hispanic/Latino…
It reports 29% mortality rate in hospitalized patients and higher risk for severe outcomes in Black and Hispanic/Latino patients. Race/ethnicity is the strongest risk factor #MMSM #COVID19nCancer #healthdisparities #Myeloma Read more here> https://t.co
It reports 29% mortality rate in hospitalized patients and higher risk for severe outcomes in Black and Hispanic/Latino patients. Race/ethnicity is the strongest risk factor. Read more: https://t.co/a7BBjSVyX9 #MMSM #COVID19nCancer #healthdisparities #Mye